The FDA didn't approve the oral thrombin inhibitor's 110-mg twice-daily dosage for nonvalvular AF, but any disadvantages it has compared with the approved 150-mg twice-daily dosage mostly went away...

For complete story visit theheart.org.

Top-line results for the study were released early this morning; full study details will be presented at the upcoming ESC 2013 meeting in September.

For complete story visit theheart.org.

Coprescription of clarithromycin or erythromycin with a statin that is metabolized by CYP3A4 increases the risk for statin toxicity in older adults, according to a population-based cohort study.

For complete story visit theheart.org.

Good news for caffeine lovers! A large French analysis showed that drinking tea or coffee was associated with a small but statistically significant reduction in systolic and diastolic blood pressure.

For complete story visit theheart.org.

So concluded a new laboratory study, with acknowledged limitations, that simulated the in vivo stresses imposed on implanted leads.

For complete story visit theheart.org.

Cardiologists with an eye to the burgeoning numbers of diabetics on their caseloads may learn new insights from the two trials as well as a host of smaller studies coming out at the ADA meeting later...

For complete story visit theheart.org.

At the ESH meeting, two experts took opposing views concerning the current war on salt. One believes the current salt/sodium targets were simply pulled out of a hat and have no scientific basis at...

For complete story visit theheart.org.

Daytime blood pressure measured by 24-hour ambulatory blood-pressure monitoring was reduced by 8.9/3.7 mm Hg, report investigators. The data suggest that the addition of spironolactone might be...

For complete story visit theheart.org.

While the office-measured 17.6-mm-Hg reduction in systolic blood pressure is within the range of clinical-trial data, 24-hour ambulatory blood-pressure monitoring revealed a much smaller reduction....

For complete story visit theheart.org.

The new guidelines make <140 mm Hg the treatment target for all individuals, with a few minor exceptions, and say that all the drug classes have a role in reducing blood pressure. In addition, the...

For complete story visit theheart.org.